This group supports scientific and administrative oversight for preclinical chemoprevention agent development up to early phase I chemopreventive agent research using physiological endpoints in healthy volunteers. Research focuses on identifying and developing agents with the potential to block, reverse, or delay early stages of cancer, using a battery of preclinical pharmacology, toxicology, and efficacy tests, and conducting phase 1 pharmacokinetic and safety studies.
Funding Opportunities
This is a listing of Requests for Proposals and Program Announcements specific to the group's key programs.
Programs and Projects
The group administers the Rapid Access to Preventive Intervention Development (RAPID) Program: a prevention agents program, and clinical trials of chemoprevention agents.
Publications and Presentations
This section contains journal articles, clinical development plans, book and supplement citations, and an annual report.
About the Research Group
Mission, staff list, and contact information are in this section.
